Evidence map›Paper›PMID 39872382›Full record

ArticleERJ open research2025

Treatment effects of CFTR modulators on people with cystic fibrosis carrying the Q359K/T360K variant.

Karin Yaacoby-Bianu, Moshe Heching, Mordechai R Kramer, Einat Shmueli, Dario Prais, François Vermeulen, Anabela S Ramalho, Raya Cohen, Galit Livnat, Michal Shteinberg

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karin Yaacoby-BianuPediatric Pulmonology Unit and CF Center, Carmel Medical Center, Haifa, Israel.
Moshe HechingPulmonology Institute and CF Center, Rabin Medical Center, Petah Tiqva, Israel.ORCID https://orcid.org/0000-0001-8073-3973
Mordechai R KramerPulmonology Institute and CF Center, Rabin Medical Center, Petah Tiqva, Israel.
Einat ShmueliPediatric Pulmonology Institute and CF Center, Schneider Children's Medical Center, Petah Tiqva, Israel.
Dario PraisSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID https://orcid.org/0000-0002-4165-0144
François VermeulenCF Research Lab, Woman and Child Unit, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Anabela S RamalhoCF Research Lab, Woman and Child Unit, Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Raya CohenB. Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Galit LivnatPediatric Pulmonology Unit and CF Center, Carmel Medical Center, Haifa, Israel.
Michal ShteinbergB. Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.ORCID https://orcid.org/0000-0002-0432-3398

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39872382
PMCPMC11770694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.